(Q45245254)

11 December 2017

title

Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease (English)

1 reference

11 December 2017

3

1 reference

11 December 2017

Diederick Stoffers

1

0 references

Henk W. Berendse

series ordinal

6

object named as

Henk W Berendse

1 reference

11 December 2017

Jan Booij

2

1 reference

11 December 2017

Ania Winogrodzka

series ordinal

4

1 reference

11 December 2017

Erik C Wolters

series ordinal

5

1 reference

11 December 2017

language of work or name

1 reference

29 January 2005

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

11 December 2017

published in

1 reference

11 December 2017

volume

32

1 reference

11 December 2017

issue

6

1 reference

11 December 2017

page(s)

689-695

1 reference

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-004-1733-4

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-004-1733-4

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-004-1733-4

PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-004-1733-4

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

12 December 2020

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

1 reference

12 December 2020

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

12 December 2020

Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.

1 reference

12 December 2020

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

1 reference

12 December 2020

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

1 reference

12 December 2020

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

12 December 2020

Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.

1 reference

12 December 2020

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

1 reference

12 December 2020

Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.

1 reference

12 December 2020

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

12 December 2020

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study

1 reference

12 December 2020

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

1 reference

12 December 2020

Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.

1 reference

12 December 2020

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

12 December 2020

Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.

1 reference

12 December 2020

Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers

1 reference

12 December 2020

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

1 reference

12 December 2020

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

12 December 2020

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

12 December 2020

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

1 reference

12 December 2020

[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Consensus statement on the diagnosis of multiple system atrophy

1 reference

12 December 2020

Accuracy of clinical diagnosis in parkinsonism--a prospective study

1 reference

12 December 2020

[123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls

1 reference

12 December 2020

Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration

1 reference

12 December 2020

123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism

1 reference

12 December 2020

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.

1 reference

12 December 2020

10.1007/S00259-004-1733-4

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1044419132

0 references

1 reference